- Home
- LRHC vs BRTX Comparison
LRHC vs BRTX Comparison
Compare LRHC & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- BRTX
- Stock Information
- Founded
- LRHC 2004
- BRTX 1997
- Country
- LRHC United States
- BRTX United States
- Employees
- LRHC N/A
- BRTX N/A
- Industry
- LRHC
- BRTX Managed Health Care
- Sector
- LRHC
- BRTX Health Care
- Exchange
- LRHC Nasdaq
- BRTX Nasdaq
- Market Cap
- LRHC 5.6M
- BRTX 12.6M
- IPO Year
- LRHC 2023
- BRTX N/A
- Fundamental
- Price
- LRHC $7.46
- BRTX $1.60
- Analyst Decision
- LRHC
- BRTX Strong Buy
- Analyst Count
- LRHC 0
- BRTX 1
- Target Price
- LRHC N/A
- BRTX $18.00
- AVG Volume (30 Days)
- LRHC 477.5K
- BRTX 262.2K
- Earning Date
- LRHC 08-14-2025
- BRTX 08-12-2025
- Dividend Yield
- LRHC N/A
- BRTX N/A
- EPS Growth
- LRHC N/A
- BRTX N/A
- EPS
- LRHC N/A
- BRTX N/A
- Revenue
- LRHC $73,874,281.00
- BRTX $391,000.00
- Revenue This Year
- LRHC N/A
- BRTX $391.52
- Revenue Next Year
- LRHC N/A
- BRTX $3.50
- P/E Ratio
- LRHC N/A
- BRTX N/A
- Revenue Growth
- LRHC 90.36
- BRTX 161.54
- 52 Week Low
- LRHC $6.40
- BRTX $1.21
- 52 Week High
- LRHC $142.40
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- LRHC 40.74
- BRTX 51.29
- Support Level
- LRHC $7.01
- BRTX $1.51
- Resistance Level
- LRHC $18.64
- BRTX $1.72
- Average True Range (ATR)
- LRHC 1.69
- BRTX 0.10
- MACD
- LRHC -0.28
- BRTX 0.00
- Stochastic Oscillator
- LRHC 8.66
- BRTX 67.54
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.